TearScience Receives $70M in Funding

TearScience, a medical device company based in Morrisville, N.C., has received up to $70 million from HealthCare Royalty Partners in order to market the TearScience system for people suffering from dry eye conditions.

Advertisement

The TearScience system is designed to help physicians diagnosis and treat dry eye conditions.

HealthCare Royalty Partners, based in Stamford, Conn., is an international healthcare investment firm.

More Articles on Ophthalmology:
American Academy of Ophthalmology Joins Choosing Wisely Campaign
Lahey Hospital & Medical Center Acquires Essex VitreoRetinal Services
California Laws Prohibiting ‘One-Stop- Optician Stores Remain Intact

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.